Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 2/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 11/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.50 |
| ▸ | PRCP | P42785 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 2/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24444406 | 1.00 | CASP2 (0.54) | CASP2NAAAEPHX1EPHX2DNM1 | |
| SCHEMBL24412938 | 1.00 | CASP2 (0.54) | CASP2NAAAEPHX1EPHX2DNM1 | |
| SCHEMBL24412627 | 0.89 | CASP2 (0.54) | CASP2NAAAEPHX1EPHX2DNM1 | |
| SCHEMBL24412637 | 0.87 | CASP2 (0.53) | CASP2NAAAEPHX1EPHX2DNM1 | |
| SCHEMBL9285521 | 0.84 | GNAI3 (0.52) | CASP2NAAAEPHX1DNM1PRCP | |
| SCHEMBL24435347 | 0.83 | DNM1 (0.49) | CASP2NAAAEPHX1EPHX2DNM1 | |
| SCHEMBL24412691 | 0.81 | BCHE (0.53) | CASP2NAAAEPHX1EPHX2DNM1 | |
| SCHEMBL24412677 | 0.80 | THRA (0.42) | CASP2NAAAEPHX1EPHX2 | |
| SCHEMBL24412721 | 0.80 | NAAA (0.54) | CASP2NAAAEPHX1EPHX2DNM1 | |
| SCHEMBL12792107 | 0.78 | CASP2 (0.51) | CASP2NAAAEPHX1EPHX2DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220145045-A1 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | SHAOXING RUIKANG BIOTECHNOLOGIES CO INC (CN) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220145045-A1 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | PCNA, NCL, PNN | CASP2 4043/4885NAAA 172/4885EPHX1 3022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.